Philip Puchas

Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis

Lijun Liao, Kai Markus Schneider, Eric J. C. Gálvez et al. · Gut · 2019 · 178 citations

Life Sciences, Immunology, Pathology +17

The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer

Charlotte Dahlem, Ahmad Barghash, Philip Puchas et al. · International Journal of Molecular Sciences · 2019 · 77 citations · Full text

Medicine, Molecular Biology, Oncology +11

New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma

Nicole Golob‐Schwarzl, Philip Puchas, Margit Gogg-Kamerer et al. · Anticancer Research · 2020 · 30 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data

Alexander Olkus, Aurelie Tomczak, Anne Berger et al. · Targeted Oncology · 2024 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients

Anna L. Lembeck, Philip Puchas, Georg C. Hutterer et al. · Non-Coding RNA · 2020 · 17 citations · Full text

Medicine, Oncology, Pathology +17